SUBCLONING AND ASSESSMENT OF THE EXPRESSION OF SYNTHETIC BOTULINUM NEUROTOXIN TYPE B BINDING DOMAIN (BD/B)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BARADARAN MAJID; EBRAHIMI FIROUZ; NAZARIAN SHAHRAM; HAJIZADEH ABBAS; TARVERDIZADEH YOUSOF

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Qom University of Medical Sciences Journal Year:2016 | Volume:10 | Issue:5 Page(s): 29-37

Download Full-Text

Persian Verion

View:

822

Download:

Cites:

Information Journal Paper

Title

SUBCLONING AND ASSESSMENT OF THE EXPRESSION OF SYNTHETIC BOTULINUM NEUROTOXIN TYPE B BINDING DOMAIN (BD/B)

Author(s)

Keywords

CLOSTRIDIUM BOTULINUMQ1

GENE EXPRESSIONQ1

VACCINESQ2

SYNTHETICQ2

Abstract

Background and Objectives: Botulism syndrome is caused by CLOSTRIDIUM BOTULINUM neurotoxin. This neurotoxin has 7 serotypes, from A to G. The best way to prevent botulism syndrome caused by BoNT/B is immunization with recombinant binding domains of BoNT/B (due to containing sufficient epitopes to stimulate the immune system). In this study, the expression of the BoNT/B binding domain as a candidate vaccine, was investigated.Methods: At first, the sequence of the BoNT/B binding domain gene was obtained from NCBI website with accession number of EF028399.1. After codon optimization, the gene was synthesized in pUC18 vector. Then, the gene was subcloned in pET32a (+) expression vector that carries an ampicillin selection marker. PCR, enzymatic digestion, and sequencing were used to confirm subcloning accuracy, and E. coli BL21 (DE3) was used for the expression analysis. The accuracy of protein expression was evaluated by electrophoresis and western blotting.Results: PCR reaction, enzymatic digestion, and sequencing confirmed that the gene of interest has been subcloned appropriately in the vector. The expression analysis by SDS-PAGE and subsequently western blotting, showed that the protein of interest is not expressed in the mentioned expression strain.Conclusion: Although the gene was successfully subcloned in pET32a (+) vector, no significant expression of the gene was observed.

Cites

No record.

References

No record.

Cite

APA: Copy

BARADARAN, MAJID, EBRAHIMI, FIROUZ, NAZARIAN, SHAHRAM, HAJIZADEH, ABBAS, & TARVERDIZADEH, YOUSOF. (2016). SUBCLONING AND ASSESSMENT OF THE EXPRESSION OF SYNTHETIC BOTULINUM NEUROTOXIN TYPE B BINDING DOMAIN (BD/B). QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL, 10(5), 29-37. SID. https://sid.ir/paper/132290/en

Vancouver: Copy

BARADARAN MAJID, EBRAHIMI FIROUZ, NAZARIAN SHAHRAM, HAJIZADEH ABBAS, TARVERDIZADEH YOUSOF. SUBCLONING AND ASSESSMENT OF THE EXPRESSION OF SYNTHETIC BOTULINUM NEUROTOXIN TYPE B BINDING DOMAIN (BD/B). QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL[Internet]. 2016;10(5):29-37. Available from: https://sid.ir/paper/132290/en

IEEE: Copy

MAJID BARADARAN, FIROUZ EBRAHIMI, SHAHRAM NAZARIAN, ABBAS HAJIZADEH, and YOUSOF TARVERDIZADEH, “SUBCLONING AND ASSESSMENT OF THE EXPRESSION OF SYNTHETIC BOTULINUM NEUROTOXIN TYPE B BINDING DOMAIN (BD/B),” QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL, vol. 10, no. 5, pp. 29–37, 2016, [Online]. Available: https://sid.ir/paper/132290/en

Related Journal Papers